Skin and skin structure infections: treatment with newer generation fluoroquinolones.
about
Antibacterial Evaluation of Synthetic Thiazole Compounds In Vitro and In Vivo in a Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infection Mouse ModelHyaluronan breakdown contributes to immune defense against group A StreptococcusGlobal fluoroquinolone resistance epidemiology and implictions for clinical use.Discovery and characterization of aryl isonitriles as a new class of compounds versus methicillin- and vancomycin-resistant Staphylococcus aureusAnti-infectious and anti-inflammatory effects of peptide fragments sequentially derived from the antimicrobial peptide centrocin 1 isolated from the green sea urchin, Strongylocentrotus droebachiensis.Moxifloxacin in complicated skin and skin structure infections (cSSSIs): A prospective, international, non-interventional, observational study.Personalized therapeutics for levofloxacin: a focus on pharmacokinetic concerns.A mathematical model to evaluate the routine use of fecal microbiota transplantation to prevent incident and recurrent Clostridium difficile infection.Phenylthiazole Antibacterial Agents Targeting Cell Wall Synthesis Exhibit Potent Activity in Vitro and in Vivo against Vancomycin-Resistant Enterococci.Preparation oral levofloxacin colon-specific microspheres delivery: in vitro and in vivo studies.Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogens.
P2860
Q28550691-9186F5B9-F2C2-4E66-864B-BB1C01A6BB02Q34245010-97A6CE5F-B7E5-4BFF-9F40-59533F321B49Q36337074-4AA37425-C637-49DA-8185-942BD4F87607Q36392641-0A450F08-6C0B-4354-9844-705BF3F1AD90Q36578817-10EB5911-8A6F-4C3E-8CFF-95AF39CAA37AQ36997690-2349CFC8-5963-436B-B1E6-09490BC3FB6BQ37678156-162B46C0-F139-4FA4-B230-5EBE98FE03A0Q37688458-7E448B70-1E61-48AD-A989-81D157F9763EQ40313144-FEE8B8C6-45DA-4A55-8140-539FAA98EF3AQ53523560-13CA70D7-4088-4A15-BE85-471DA679F6E0Q55432018-1EAD7B3D-728B-4B60-BFF6-EC830A38ADF5
P2860
Skin and skin structure infections: treatment with newer generation fluoroquinolones.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Skin and skin structure infections: treatment with newer generation fluoroquinolones.
@en
Skin and skin structure infections: treatment with newer generation fluoroquinolones.
@nl
type
label
Skin and skin structure infections: treatment with newer generation fluoroquinolones.
@en
Skin and skin structure infections: treatment with newer generation fluoroquinolones.
@nl
prefLabel
Skin and skin structure infections: treatment with newer generation fluoroquinolones.
@en
Skin and skin structure infections: treatment with newer generation fluoroquinolones.
@nl
P2093
P2860
P1476
Skin and skin structure infections: treatment with newer generation fluoroquinolones.
@en
P2093
Gail Gesin
Jason Kubert
Kurt Weber
Philip Giordano
P2860
P304
P356
10.2147/TCRM.2007.3.2.309
P577
2007-06-01T00:00:00Z